Ledipasvir-sofosbuvir for 8 weeks in non-cirrhotic patients with previously untreated genotype 1 HCV Infection ± HIV-1 co-infection | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Ledipasvir-sofosbuvir for 8 weeks in non-cirrhotic patients with previously untreated genotype 1 HCV Infection ± HIV-1 co-infection

Isakov V, Gankina N, Morozov V, et al. Ledipasvir-sofosbuvir for 8 weeks in non-cirrhotic patients with previously untreated genotype 1 HCV Infection ± HIV-1 co-infection. Clin Drug Investig. 2018;38(3):239-247.

Publication Type:

Journal Article

Authors:

Isakov, V; Gankina, N; Morozov, V; et, al

Source:

Clin Drug Investig, Volume 38, Issue 3, p.239-247 (2018)

Cited On:

Patients With HIV/HCV Coinfection

Export Citation:

RIS Format

Top